Back to announcement
20250630_BMHS_Laporan Informasi dan Fakta Material_31909815_lamp1.pdf
Other Text extracted BMHSSource file signed link, expires in 15 minutes
Extracted text 2
Page 1 OCR 0.918
bmhs
since 1973
G
Jakarta, 2 Juli 2025/ July 2”4, 2025
No. : 337-K/PD/BMHS/VII/2025
Lampiran/Att. : -
Perihal/ Re. : Keterbukaan Informasi Hasil Pelaksanaan MESOP PT Bundamedik Tbk (“Perseroan”)/
Disclosure of Information on the Results of MESOP Implementation of PT Bundamedik
Tbk (the “Company”)
Kepada Yth./To:
Otoritas Jasa Keuangan ("OJK")
Gedung Sumitro Djojohadikusumo
Jl. Lapangan Banteng Timur No. 2-4
Jakarta Pusat - 10710
U.p./Attn.To : Yth. Bapak I Gede Nyoman Yetna
Direktur Penilaian Perusahaan/
Director of Corporate Assessment
Dengan hormat, Yours faithfully,
Referring to the Company Letter 137-
K/PD/BMHS/IV/2025 dated April 234, 2025
regarding Information on Planned
Implementation Period of Phase 1 Window
Exercise I and Phase II Window Exercise I of 2025
Merujuk kepada Surat Perseroan Nomor 137-
K/PD/BMHS/IV/2025 tanggal 23 April 2025
perihal Informasi Rencana Periode Pelaksanaan
Tahap I Window Exercise | dan Tahap II Window
Exercise | Tahun 2025 Management and
Employee Stock Option Program (“MESOP”)
PT Bundamedik Tbk. Maka, sehubungan dengan
periode pelaksanaan MESOP pada tanggal 1 Mei
2025 sampai dengan tanggal 20 Juni 2025 dan
sesuai dengan ketentuan yang diatur dalam Surat
Edaran BEI Nomor SE-00002/BEI/03-2020, maka
dengan ini Perseroan menyampaikan
keterbukaan informasi terkait dengan hasil
pelaksanaan MESOP sebagai berikut:
Program Management and Employee Stock
Option Program (“MESOP”) of PT Bundamedik
Tbk. Then in accordance to the implementation
period of the MESOP from May 1'', 2025 to June
20”, 2025 and according to the provisions
stipulated in IDX Circular Letter Number SE-
00002/BE1/03-2020, the Company hereby submit
information disclosure related to the results of
MESOP Implementation are as follows:
Penjelasan/Explanation
O nihil/ none
No. Keterangan/Description
1 Jumlah opsi yang telah dilaksanakan hak
konversinya dan jumlah saham baru yang telah
diterbitkan untuk periode pelaksanaan Tahap |
Window Exercise I/ The Number of options with
conversion rights that have been exercised and
number of new shares issued for the period of
Phase I Window Exercise I.
1g
PT Bundamedik Tbk
Jl. Teuku Cik Ditiro No. 28, Menteng - Jakarta Pusat 10350, Indonesia
Head Office: BMHS Diagnos Tower 6" - 7" Floor
Jl. Teuku Cik Ditiro No. 11, Menteng - Jakarta Pusat 10350, Indonesia
Because Zanuly /Male
www.bmhs.co.id @ 021-50980799 @
Page 2 OCR 0.922
(@ bmhs N since 1973 2. Jumlah opsi yang telah dilaksanakan hak | Onihil/ none konversinya dan jumlah saham baru yang telah diterbitkan untuk periode pelaksanaan Tahap II Window Exercise I/ The Number of options with conversion rights that have been exercised and number of new shares issued for the period of Phase II Window Exercise I. 3. Jumlah opsi yang belum dilaksanakan dan masih | 22.500.000 saham/ shares berlaku untuk periode pelaksanaan Tahap | Window Exercise I / The number of options that have not been exercised and are still valid for the period of Phase I Window Exercise I. 4 Jumlah opsi yang belum dilaksanakan dan masih | 2.500.000 saham/ shares berlaku untuk periode pelaksanaan Tahap II Window Exercise | / The number of options that have not been exercised and are still valid for the period of Phase II Window Exercise I. 5. Jumlah saham MESOP yang belum dilaksanakan | O nihil/ none dan habis masa berlakunya untuk periode pelaksanaan Tahap | Window Exercise | / The number of MESOP shares that have not been exercised and expired for the period of Phase I Window Exercise I. 6. Jumlah saham MESOP yang belum dilaksanakan | O nihil/ none dan habis masa berlakunya untuk periode pelaksanaan Tahap II Window Exercise I/ The number of MESOP shares that have not been exercised and expired for the period of Phase II Window Exercise I. Demikian keterbukaan informasi ini kami Hereby we convey this disclosure of information. sampaikan. Atas perhatian dan kerjasamanya, Thank you for your attention and cooperation. kami ucapkan terima kasih. Hormat kami/Regards, PT Bundamedik Tbk Agus Ge BIA dik Tbk $: President Director PT Bundamedik Tbk Jl. Teuku Cik Ditiro No. 28, Menteng - Jakarta Pusat 10350, Indonesia Head Office: BMHS Diagnos Tower 6" - 7" Floor Because Pemula (Malers Jl. Teuku Cik Ditiro No. 11, Menteng - Jakarta Pusat 10350, Indonesia www.bmhs.co.id @ 021-50980799 @ BNN
Names mentioned 4 people and organisations named in the text · linked when the evidence is strong
unresolved
person
I Gede Nyoman Yetna
p.1
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.